GlassScriptPhysician profile
Roxana G Kline
NPI 1215037981
$11,504.86
in general payments reported to CMS, 2019-2025
30 companies · $5,018 in 2025
The $5,018 reported for 2025 was more than what 84% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,010 · 2020: $567 · 2021: $785 · 2022: $2,806 · 2023: $493 · 2024: $827 · 2025: $5,018.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,661 · Consulting Fee: $1,500 · Travel and Lodging: $1,176 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,661.39 |
| Consulting Fee | $1,500.00 |
| Travel and Lodging | $1,176.49 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Silk Road Medical, INC. | $2,519.93 | 2022-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Convatec INC. | $2,180.38 | 2024-2025 | |
| Atrium Medical Corporation | $1,500.00 | 2025 | |
| Becton, Dickinson and Company | $1,039.38 | 2023-2025 | Bardport M.R.I. |
| Endologix LLC | $962.08 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $855.51 | 2019-2024 | Xarelto |
| Heron Therapeutics, INC. | $379.68 | 2021-2024 | Zynrelef |
| Bard Peripheral Vascular, INC. | $356.07 | 2019-2025 | Denali Vena Cava Filter, Powerport M.R.I. Implantable Port, Trek |
| Angiodynamics, INC. | $297.39 | 2019-2025 | Bioflo, Venacure 1470 Pro, Auryon Laser System 100-120 Vac |
| Neuros Medical, INC. | $178.82 | 2025 | Altius |
| Boston Scientific Corporation | $175.83 | 2020-2025 | Enroute Transcarotid Neuroprotection System, Varithena Administration Pack |
| E.R. Squibb & Sons, L.L.C. | $153.75 | 2019-2025 | Eliquis |
| Pfizer INC. | $144.33 | 2019-2023 | |
| Aroa Biosurgery Incorporated | $130.54 | 2019-2020 | |
| Smith+Nephew, INC. | $124.69 | 2019 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $108.82 | 2022-2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Atricure, INC. | $88.64 | 2021-2023 | |
| Innocoll Pharmaceuticals Limited | $50.64 | 2021-2022 | |
| Cook Medical LLC | $34.37 | 2020-2023 | Zilver Ptx |
| Cashflow Solutions, LLC | $33.82 | 2025 | Pcd-52 737a (US) White, Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt |
| Merck Sharp & Dohme LLC | $30.37 | 2023 | Keytruda |
| Kowa Pharmaceuticals America, INC. | $26.65 | 2022 | |
| Lemaitre Vascular, INC. | $20.83 | 2019 | |
| Ethicon US, LLC | $19.45 | 2019 | |
| Kci USA, INC. | $16.68 | 2020 | |
| Tactile Systems Technology INC | $16.39 | 2020 | |
| Merit Medical Systems INC | $16.36 | 2025 | Wrapsody Stent Graft, Surfacer Inside-Out Catheter |
| Kiniksa Pharmaceuticals International, Plc | $16.30 | 2024 | Arcalyst |
| Medtronic, INC. | $13.59 | 2024 | Endurant Iis |
| Daiichi Sankyo INC. | $13.57 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roxana Kline listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.